Orange Book product · Brand (NDA)
VIREAD
TENOFOVIR DISOPROXIL FUMARATE
At a glance
Jan 18, 2012
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 18, 2012
14 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
TENOFOVIR DISOPROXIL FUMARATE
Strength
150MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 021356
Product number
002
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2012VIREADBrand (NDA)
NDA 022577 · GILEAD SCIENCES INC
- 2025TENOFOVIR DISOPROXIL FUMARATEGeneric (ANDA)
ANDA 206157 · MICRO LABS
- 2024TENOFOVIR DISOPROXIL FUMARATEGeneric (ANDA)
ANDA 079071 · PHARMOBEDIENT
- 2023TENOFOVIR DISOPROXIL FUMARATEGeneric (ANDA)
ANDA 211337 · REYOUNG
- 2018TENOFOVIR DISOPROXIL FUMARATEGeneric (ANDA)
ANDA 206569 · PHARMOBEDIENT
- 2018TENOFOVIR DISOPROXIL FUMARATEGeneric (ANDA)
ANDA 206481 · CHARTWELL
- 2018TENOFOVIR DISOPROXIL FUMARATEGeneric (ANDA)
ANDA 209498 · QILU
- 2018TENOFOVIR DISOPROXIL FUMARATEGeneric (ANDA)
ANDA 209550 · CHARTWELL RX
- 2018TENOFOVIR DISOPROXIL FUMARATEGeneric (ANDA)
ANDA 090647 · AUROBINDO PHARMA
- 2018TENOFOVIR DISOPROXIL FUMARATEGeneric (ANDA)
ANDA 078800 · CIPLA
- 2018TENOFOVIR DISOPROXIL FUMARATEGeneric (ANDA)
ANDA 090636 · HETERO LABS LTD III
- 2018TENOFOVIR DISOPROXIL FUMARATEGeneric (ANDA)
ANDA 203232 · MACLEODS PHARMS LTD
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
